Johns Hopkins ABX Guide
Tenofovir AF
INDICATIONS
FDA
FDA
Treatment of HIV-1 infection as part of a single-tablet regimen (STR), Genvoya or Odefsey, or NRTI combination tablet Descovy, for adults and pediatric patients 12 years of age and older who are treatment naive or to replace the current antiretroviral regimen in those who are virologically suppressed
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: November 8, 2016
Citation
Smith, Janessa M. "Tenofovir AF." Johns Hopkins ABX Guide, The Johns Hopkins University, 2016. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540677/all/Tenofovir_AF.
Smith JM. Tenofovir AF. Johns Hopkins ABX Guide. The Johns Hopkins University; 2016. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540677/all/Tenofovir_AF. Accessed December 3, 2023.
Smith, J. M. (2016). Tenofovir AF. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540677/all/Tenofovir_AF
Smith JM. Tenofovir AF [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2016. [cited 2023 December 03]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540677/all/Tenofovir_AF.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tenofovir AF
ID - 540677
A1 - Smith,Janessa,PharmD, BCPS
Y1 - 2016/11/08/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540677/all/Tenofovir_AF
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
